Senior Scientist at GlaxoSmithKline Biologicals
Brussels Area, Belgium
- Current
-
- Senior Scientist at GlaxoSmithKline Biologicals
- Past
-
- Research Assistant at Université catholique de Louvain
- Postdoctoral fellow at Swiss Research Institute for Cancer Research
- Postdoctoral fellow at Ludwig Institute For Cancer Research
- PhD at Institut Gustave Roussy
- PhD student at GABBA PhD programm
- PhD Student at Dana-Farber Cancer Institute
- Science trainee at IPATIMUP
- Education
-
- Universidade do Porto
- Universidade do Porto
- Recommended
-
2 people have recommended Pedro - Connections
-
33
connections
- Industry
- Research
- Websites
Pedro Alves’s Summary
Human anti-tumor immunotherapeutic strategies: antigen discovery and research development.
Immunological monitoring of cancer patients vaccinated with peptide and DNA-based vaccines.
Currently, evaluating the immunological performance of GlaxoSmithKline's phase II clinical trial on melanoma patients vaccinated with MAGE-3 tumor antigen.
Check for published publications in scientific journals and further bio on:
http://pmsalves.tripod.com/CV/cv.html
Pedro Alves’s Specialties:
Human and mouse immunology.
Human and mouse tumor immunology.
In vitro human and mouse cell culture.
Research project management.
Pedro Alves’s Experience
-
Senior Scientist
GlaxoSmithKline Biologicals
(Privately Held; GSK; Pharmaceuticals industry)
April 2009 — Present (4 months)
-
Research Assistant
Université catholique de Louvain
(Educational Institution; Research industry)
June 2007 — March 2009 (1 year 10 months)
Implementation, validation and development of immunological monitoring methods for comprehensive evaluation of cancer patients performance and follow-up after vaccination with anti-tumor vaccines, using state-of-art immunological technologies.
Currently evaluating a subset of melanoma patients vaccinated by GSK Bio with MAGE-A3 tumor antigen on a phase II clinical trial. -
Postdoctoral fellow
Swiss Research Institute for Cancer Research
(Non-Profit; Research industry)
October 2005 — June 2007 (1 year 9 months)
Transcriptional analysis of colorectal cancer, identification and immunological evaluation of anti-tumor novel tumor antigens in human colorectal cancer.
-
Postdoctoral fellow
Ludwig Institute For Cancer Research
(Non-Profit; Research industry)
May 2003 — September 2005 (2 years 5 months)
Validation of T cell epitopes from colorectal colon associated tumor antigens for ex vivo and in vitro characterization of anti-tumor T cell responses from colorectal cancer patients.
Implementation of colorectal cancer tissue, blood and serum bank for immunological/proteomic/transcriptomics analysis. -
PhD
Institut Gustave Roussy
(Research industry)
2000 — 2003 (3 years)
-
PhD student
GABBA PhD programm
(Research industry)
1997 — 2003 (6 years)
Programa Graduado nas Areas de Biologia Básica e Aplicada da Universidade do Porto. Aluno da edição de 1997.
-
PhD Student
Dana-Farber Cancer Institute
(Non-Profit; 1001-5000 employees; Hospital & Health Care industry)
1999 — 2000 (1 year)
-
Science trainee
IPATIMUP
(Non-Profit; Research industry)
January 1996 — September 1998 (2 years 9 months)
Pedro Alves’s Education
-
Universidade do Porto
Doctoral , Tumor Immunology , 1999 — 2003
-
Universidade do Porto
BSC , Biology , 1991 — 1995
Additional Information
Pedro Alves’s Websites:
Pedro Alves’s Groups:
-
Universidade do Porto Alumni -
Biotech & Pharma Professionals Network -
The Star Tracker -
Traditional Film Photographers -
BSD UNIX -
Graduate Program in Areas of Basic and Applied Biology - GABBA
Pedro Alves’s Contact Settings
Interested In:
- career opportunities
- job inquiries
- expertise requests
- reference requests
- getting back in touch
